Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults With HIV (INSTINCT/GESIDA10918 Study). - Serrano-Villar S; Martín-Pedraza L; Tiraboschi J; Novella M; Cabello-Úbeda A; López-Cortés L; Busca C; Torralba M; Crusells MJ; Hidalgo-Tenorio C; Estrada V; Del Amo-de Palacios A; et al. (Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2026)